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Purpose: We examined changes in the clinicopathologic characteristics of renal cell car-
cinoma (RCC) in the past 25 years and aimed to obtain indicators for its diagnosis and 
treatment. 
Materials and Methods: The medical records of 563 patients with confirmed primary 
RCC after surgical treatment from 1985 to 2010 at Seoul St. Mary’s Hospital were retro-
spectively reviewed. Patient and tumor characteristics were compared over 3 time peri-
ods (period 1: 1985-1994, period 2: 1995-2004, period 3: 2005-2010).
Results: Period 1 included 65 patients, period 2 included 183 patients, and period 3 in-
cluded 315 patients, showing an exponential growth in the number of patients. 
Frequency was highest in the late 50s age group. The review of clinical symptoms 
showed that incidental diagnosis increased significantly. The tumor size at diagnosis 
gradually decreased and the proportion of small tumors less than 4 cm increased 
remarkably. Concerning tumor spread, organ-confined tumors (T1-2N0M0) increased 
and distant metastasis decreased. Histologically, the clear cell type made up the great-
est proportion, about 90% in each period, but subtypes besides the clear cell type in-
creased over the study period. The rate of nephron-sparing surgery increased, and exo-
phytic masses were the most common. 
Conclusions: Our review of the recent 25 year’s worth of data on RCC from Seoul St. 
Mary’s Hospital showed that the incidental diagnosis of RCC increased over the study 
period in accordance with the development of screening tests. Tumor size decreased 
in accordance with the progress in imaging modalities. In the future, multicenter re-
search will be needed to analyze the characteristics of whole renal cancer in Korea. 
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Renal cell carcinoma (RCC) represents 3% of all malignant 
tumors in adults and 85% of all primary malignant kidney 
tumors [1]. According to data from the Korea Central 
Cancer Registry (KCCR), in 2007, the incidence of RCC was 
5.8 out of 100,000 persons and RCC constituted 1.8% of all 
cancers [2]. Moreover, the incidence is gradually increas-
ing, and incidental diagnosis of early-stage disease is also 
increasing as the result of general health screening, ultra-
sonography, and computed tomography (CT) scanning 
[3-5]. Because the incidence of RCC grew considerably 
among domestic patients, increasing from 3.0 in 1999 to 5.8 
out of 100,000 persons in 2007 [2], it is considerably im-
portant to study the characteristics of RCC in Korea 
through overall analysis to improve its treatment and 
prognosis. We intended to present guidelines for the diag-
nosis and treatment of RCC in Korea by studying changes 
in the clinicopathological characteristics of RCC over the 
past 25 years.Korean J Urol 2011;52:110-114
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TABLE 1. Patient characteristics and distribution of clinical symptoms according to time period
Parameters Period 1 Period 2 Period 3 p-value
No. of patients  65 183 315
Mean age  54.2±10.5 55.2±12.2 56.1±11.8 0.428
Young age (≤40 yr)   7 (10.7%)   22 (12.0%) 28 (8.9%) 0.527
Sex (male:female) 1.24 2.10 2.12 0.134
Mean BMI 23.5±2.9 23.7±3.4 24.2±3.2 0.172
Clinical symptom
　Incidental (%) 22 (33.8) 111 (60.7) 229 (72.7) ＜0.001
　Symptomatic (%) 37 (56.9)   58 (31.7)   69 (21.9)
　Other medical condition (%) 6 (9.3) 14 (7.6) 17 (5.4)
BMI: body mass index
FIG. 1. Age distribution of the entire group of patients studied.
MATERIALS AND METHODS
The medical records of 563 patients with confirmed pri-
mary RCC after surgical treatment from 1985 to 2010 at 
Seoul St. Mary’s Hospital were retrospectively reviewed. 
All patients underwent either radical nephrectomy (476 
patients, 84.5%) or partial nephrectomy (87 patients, 
15.5%).
The following variables were determined in each case: 
age at diagnosis, sex, clinical symptoms, tumor size, histo-
logic subtype, TNM stage, Fuhrman grade, and surgical 
approach. Clinical symptoms were divided into 3 cases: the 
first was the case of incidental finding during a general 
health screening or during follow-up for other diseases, the 
second was the case of typical symptoms such as hematuria 
or flank pain, and the third was the case of being found dur-
ing an examination for another abnormal medical symp-
tom. Tumor size (largest diameter) was estimated from re-
sected specimens. All histologic findings were reviewed 
retrospectively according to the 1997 UICC/AJCC classi-
fication of renal neoplasms (Storkel et al, 1997), whereas 
the Fuhrman four-grade scale (Fuhrman et al, 1982) was 
used to assess the histopathologic nuclear grade. The 2002 
AJCC TNM staging system was used to classify cancer 
stage and tumor spread [6]. Open surgery and laparoscopic 
surgery were listed for the surgical approach, but robot-as-
sisted laparoscopic surgery was added after the adoption 
of the da-Vinci
Ⓡ surgical system (Intuitive Surgical, 
Sunnyvale, CA, USA) at our hospital in 2009. 
The 25-year study period was divided into three intervals 
(period 1: 1985-1994, period 2: 1995-2004, and period 3: 
2005-2010) to investigate changes over time. The chi- 
square test and ANOVA regression analysis were used re-
spectively for the comparison of qualitative and quantita-
tive variable. Statistical significance was set at p＜0.05.
RESULTS
Of the 563 patients diagnosed as having RCC after surgical 
treatment over the past 25 years, 65 patients were included 
in period 1,183 patients were included in period 2, and 315 
patients were included in period 3, showing an exponential 
growth in the number of patients.
The mean age of all patients was 55.6 years (range, 25-86 
years), and the frequency of RCC was highest in the late 
50s age group (Fig. 1). The mean age at diagnosis did not 
change over the time period (54.2±10.5 years, 55.2±12.2 
years, and 56.1±11.8 years in the three periods, respec-
tively, p=0.428). Also, the proportion of young (≤40 years 
old) patients was not statistically different among the 
groups (p=0.527). Reviewing the male to female ratio of all 
patients, disease occurrence was about two times greater 
in male than in female patients. There were 374 male pa-
tients and 189 female patients. 
The proportion of incidentally diagnosed cases during 
general health screening or during follow-up for other dis-
eases increased significantly over the time period (33.8%, 
60.7%, and 72.7% in the three periods, respectively, p
＜0.001). In the case of being found by typical symptoms, 
hematuria and flank pain were the most common symp-
toms reported. Palpable abdominal mass and bilateral var-
icocele were also found. In the case of being found during 
an examination for another abnormal medical condition, 
the symptoms reported included high fever, abdominal dis-
comfort, poor oral intake, and anemia (Table 1).
According to the increase in incidentally diagnosed cases 
in early stages, tumor size decreased significantly over the Korean J Urol 2011;52:110-114
112 Choi et al
TABLE 2. Tumor characteristics and stage according to time period
Parameters Period 1 Period 2 Period 3 p-value
Laterality (Lt./Rt. ratio) 0.80 1.12 0.89 0.648
Tumor size (cm) 6.29±3.5 5.42±3.5 4.69±3.12 ＜0.001
Small tumor (≤4 cm) 21 (32.3%)   87 (47.5) 167 (53.0) 0.009
Tumor stage
　T1-T2 (%) 55 (84.6) 156 (85.2) 281 (89.2) 0.340
　T3-T4 (%) 10 (15.4)   27 (14.8)   34 (10.8)
Pathological nodal invasion (%)   1 (0.02)     9 (0.05)     7 (0.02) 0.284
Distant metastasis 20 (30.7)   49 (26.8)   40 (12.7) ＜0.001
Tumor spread
　Organ confined (%) 39 (60.0) 125 (68.3) 258 (81.9) ＜0.001
　Locally advanced (%) 5 (7.7)   8 (4.4) 16 (5.1)
　Metastatic (%) 21 (32.3)   50 (27.3)   41 (13.0)
TABLE 3. Histology of tumors according to time period
Parameters Period 1 Period 2 Period 3 p-value
Histology
　Clear cell (%) 59 (90.8) 166 (90.7) 273 (86.7) 0.177
　Papillary 2 9 13
　Chromophobe 0 3 14
　Sarcomatoid 3 2   4
　Others 1 3 10
Fuhrman’s grade
　Grade I/II (%) 50 (76.9) 135 (73.2) 251 (79.7) 0.297
　Grade III/V (%) 15 (23.1)   48 (26.8)   64 (20.3)
TABLE 4. Surgical approach according to time period
Parameters Period 1 Period 2 Period 3 p-value
Approach of surgery
　Open (%) 65 (100) 112 (61.2) 25 (7.9) ＜0.001
　Laparoscopic (%) 0   71 (38.8) 263 (83.5)
　Robotic (%) 0 0 27 (8.6)
Type of surgery
　Radical nephrectomy (%) 63 (96.9) 174 (95.1) 239 (75.9) ＜0.001
　NSS (%) 2 (3.1)   9 (4.9)   76 (24.1)
NSS: nephron-sparing surgery
time period studied (6.29±3.5 cm, 5.42±3.5 cm, and 4.69± 
3.12 cm, respectively, p＜0.001), and the proportion of tu-
mors less than 4 cm in size increased significantly (32.3%, 
47.5%, and 53.0%, respectively, p=0.009).
In all patients, there were 492 patients (87.3%) with a 
TNM stage of T1-T2, which was far higher than the number 
with stage T3-T4 (71 patients, 12.7%). Regarding tumor 
spread, the incidence of organ-confined tumors (T1-2N0M0) 
increased (60.0%, 68.3%, and 81.9%, respectively, p＜0.001), 
whereas that of locally advanced tumors (T3-4N0M0) and 
metastatic tumors (TanyN+M0 or TanyN0M+) decreased 
(Table 2).
Regarding histologic types, clear cell type patients were 
the most common (498 patients, 88.4%), and there was no 
chromophobe RCC, a newly established subtype of renal 
neoplasm, in period 1. However, we found that other histo-
logic subtypes besides the clear cell type were increasing 
(9.2%, 9.3%, and 13.3%, respectively), although the in-
crease was not statistically significant. The Fuhrman 
grade I/II was assigned to about three-fourths of the cases 
through all periods (76.9%, 73.2%, and 79.7%, respectively) 
(Table 3). 
Concerning the surgical approach, open surgery de-
creased and laparoscopic surgery increased (0%, 38.8%, 
and 83.5%, respectively, p＜0.001), and robot-assisted lap-
aroscopic surgery increased after the adoption of the 
da-Vinci
Ⓡ surgical system (Intuitive Surgical, Sunnyvale, 
CA, USA).
As the tumor size became smaller, the rate of neph-
ron-sparing surgery (NSS) increased (3.1%, 4.9%, and Korean J Urol 2011;52:110-114
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24.1%, respectively, p＜0.001), and exophytic masses were 
the most common tumor location (55.2%) (Table 4).
DISCUSSION
The incidence of RCC is consistently growing, and 30% of 
patients with RCC already have metastasis at the time of 
diagnosis. Among the remaining patients, metastasis oc-
curs in about 30% to 50% after surgical treatment; thus, the 
death rate is not being reduced [7,8]. Therefore, guidelines 
for treatment need to be developed by studying the charac-
teristics of RCC in Korea.
In this study, we, as have many other authors, observed 
a dramatic increase in the prevalence of incidental renal 
tumors, which progressed from 33.8% to 72.7% during a 
25-year period. Sunela et al reported that the proportion 
of incidentally diagnosed cases increased from 12% in the 
1980s to 19% in the 1990s (p＜0.01) [9], and Beisland et al 
also reported that the proportion of incidentally diagnosed 
cases increased from 21.1% in the 1980s to 37.4% in the 
1990s (p＜0.01) [10]. The current domestic incidence of 
RCC is 5.8 out of 100,000 persons, which is 60% of that in 
the United States. Thus, ultrasonography and CT scan-
ning for screening RCC may reduce cost-effectiveness. 
However, abdominal sonography or CT scanning should be 
recommended to adults older than 50, because abnormal-
ities in other organs could be detected through these exami-
nations [11,12].
Currently, the most frequent age of diagnosis of RCC is 
the 50s, although some authors have reported that the 
mean age at diagnosis is getting higher because of the wide 
application of screening tests in older men and prolonged 
life expectancy [13,14]. Luciani et al reported an increase 
in the mean age at diagnosis from 57 years in 1982-1983 
to 62.6 years in 1996-1997 [13]. Patard et al also reported 
an increase in the mean age at diagnosis from 63 years in 
1984-1992 to 65 years in 1998-2003 [14]. In this study, the 
mean age at diagnosis was 54.2 years in period 1, 55.2 years 
in period 2, and 56.1 years in period 3, which showed a slight 
increase over time, but the trend was not statistically 
significant. Furthermore, we found that domestic RCC oc-
curred in more young patients than has been reported in 
European countries. Therefore, early screening tests must 
be activated and the distinctive characteristics of RCC in 
younger patients should be identified.
In the total group of patients, RCC occurred in about two 
times more males than females; there were 374 male pa-
tients and 189 female patients. KCCR data in 2007 also re-
ported a male-to-female ratio of 2:1, and a higher occur-
rence in males than in females has also been reported in 
European countries [14,15]. Smoking, obesity, and hyper-
tension are currently discussed as causes of RCC. In addi-
tion, studies on hormonal, environmental, and hereditary 
causes have been performed but not yet confirmed. 
Continued study on the causes of the high incidence in 
males is needed [16-18].
According to the increase in incidentally diagnosed cases 
in the early stages of disease, the tumor size at diagnosis 
has decreased and the rate of NSS increased [14,19]. 
Robotic support to the operator when laparoscopic surgery 
is being performed may be one reason for the increase in 
NSS. Regarding the tumor location after the performance 
of NSS, exophytic masses were the most common, and 
among those cases, the surgical margin was positive in only 
one. In the case of endophytic masses, however, it is hard 
to detect the exact border of the tumor, and the mass is diffi-
cult to resect. The development of surgical techniques in 
NSS is necessary.
Histologically, the highest proportion of tumors were of 
the clear cell type, about 90% in each period [20,21]. The 
proportion of subtypes other than the clear cell type in-
creased gradually over the study period, but not sig-
nificantly so. Nowadays, target therapy is mainly being 
performed for metastatic RCC, but medical insurance is be-
ing applied only to the clear cell type. In addition, studies 
on the clear cell type are being actively pursued, whereas 
the other histologic subtypes are poorly researched [22,23]. 
Golimbu et al reported that other histologic subtypes have 
a lower survival rate than does the clear cell type, but not 
significantly so [24]. Because the relative incidence of other 
histologic subtypes is still low, it is hard to make a simple 
comparison. Tumor grades should be considered, and opin-
ions vary among researchers [25,26]. Recently, renal cell 
carcinoma is founded in small size compared to past, so 
prognostic factors for pT1a renal cell carcinoma will be 
more improtant in near future [27]. We suggest that a mul-
ticenter study would be needed to compare the survival rate 
and treatment effectiveness of the other histologic sub-
types in Korea.
CONCLUSIONS
Our review of the recent 25 year’s worth of data on RCC 
from Seoul St. Mary’s Hospital showed that incidental di-
agnosis has increased in accordance with the development 
of screening tests, and the incidence of disease was highest 
in the late 50s age group. Tumor size at diagnosis became 
smaller in accordance with the progress in imaging modal-
ities, and the number of small tumors should consistently 
increase in the future. NSS will play a predominant role 
in treatment. As histologic subtypes besides the clear cell 
type increase, studies of target therapy of them should be 
initiated. Because our study was a single-center experi-
ence, there were limits in representing whole renal cancer. 
In the future, multicenter research is needed to analyze the 
characteristics and trends of whole renal cancer in Korea. 
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